MACM
March Altus Capital Management Portfolio holdings
AUM
$16M
This Quarter Return
+22.62%
1 Year Return
+18.92%
3 Year Return
+153.93%
5 Year Return
–
10 Year Return
–
AUM
$330M
AUM Growth
–
Cap. Flow
+$330M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
51.11%
Holding
28
New
28
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
DexCom
DXCM
|
$29.6M |
| 2 |
MON
Monsanto Co
MON
|
$23.2M |
| 3 |
Alkermes
ALKS
|
$18.8M |
| 4 |
HCA Healthcare
HCA
|
$17.5M |
| 5 |
West Pharmaceutical
WST
|
$16.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 75.36% |
| 2 | Financials | 8.92% |
| 3 | Materials | 7.02% |
| 4 | Industrials | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
DexCom
DXCM
$29.5B
| $29.6M | 8.95% |
+834,838
| New | +$29.6M |
|
|
MON
2
DELISTED
Monsanto Co
MON
| $23.2M | 7.02% |
+198,988
| New | +$23.2M |
|
|
3
Alkermes
ALKS
$4.78B
| $18.8M | 5.7% |
+462,853
| New | +$18.8M |
|
|
4
HCA Healthcare
HCA
$94.5B
| $17.5M | 5.31% |
+367,390
| New | +$17.5M |
|
|
5
West Pharmaceutical
WST
$17.8B
| $16.5M | 5.01% |
+337,161
| New | +$16.5M |
|
|
ZLTQ
6
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $14.3M | 4.33% |
+756,505
| New | +$14.3M |
|
7
Aon
AON
$79.1B
| $12.3M | 3.73% |
+146,694
| New | +$12.3M |
|
8
Integra LifeSciences
IART
$1.18B
| $12.2M | 3.69% |
+255,406
| New | +$12.2M |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $12.2M | 3.68% |
+91,411
| New | +$12.2M |
|
10
Baxter International
BAX
$12.7B
| $12.1M | 3.67% |
+174,370
| New | +$12.1M |
|
11
Universal Health Services
UHS
$11.6B
| $11.7M | 3.56% |
+144,506
| New | +$11.7M |
|
|
AGN
12
DELISTED
ALLERGAN INC
AGN
| $11.7M | 3.55% |
+105,645
| New | +$11.7M |
|
13
Humana
HUM
$36.5B
| $11.6M | 3.52% |
+112,502
| New | +$11.6M |
|
14
Eli Lilly
LLY
$657B
| $11.6M | 3.5% |
+226,838
| New | +$11.6M |
|
|
MNK
15
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $11.6M | 3.5% |
+221,085
| New | +$11.6M |
|
16
eHealth
EHTH
$118M
| $11.3M | 3.43% |
+243,399
| New | +$11.3M |
|
17
Perrigo
PRGO
$3.27B
| $11.2M | 3.39% |
+72,955
| New | +$11.2M |
|
18
Tandem Diabetes Care
TNDM
$845M
| $11M | 3.34% |
+428,023
| New | +$11M |
|
|
CYBX
19
DELISTED
CYBERONICS INC
CYBX
| $10.9M | 3.31% |
+166,888
| New | +$10.9M |
|
20
Encompass Health
EHC
$12.3B
| $10.5M | 3.19% |
+316,462
| New | +$10.5M |
|
|
ATHN
21
DELISTED
Athenahealth, Inc.
ATHN
| $8.91M | 2.7% |
+66,226
| New | +$8.91M |
|
|
UNIS
22
DELISTED
Unilife Corporation
UNIS
| $7.38M | 2.24% |
+1,677,433
| New | +$7.38M |
|
23
Accuray
ARAY
$157M
| $5.98M | 1.81% |
+686,569
| New | +$5.98M |
|
|
MDCO
24
DELISTED
Medicines Co
MDCO
| $5.9M | 1.79% |
+152,809
| New | +$5.9M |
|
25
Marsh & McLennan
MMC
$101B
| $5.82M | 1.76% |
+120,350
| New | +$5.82M |
|